AW
ADPT icon

Avion Wealth’s Adaptive Biotechnologies ADPT Stock Holding History

Avion Wealth’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Hold
140
– – ﹤0.01% 902
2026
Q1 		$1K Hold
140
– – ﹤0.01% 953
2025
Q4 		$2K Hold
140
– – ﹤0.01% 830
2025
Q3 		$2K Hold
140
– – ﹤0.01% 819
2025
Q2 		$1K Hold
140
– – ﹤0.01% 884
2025
Q1 		$0 Buy
+140
New +$1.08K ﹤0.01% 975
2024
Q4 		– Sell
-140
Closed – – 973
2024
Q3 		$0 Hold
140
– – ﹤0.01% 960
2024
Q2 		$0 Buy
140
+1
+0.7% +$3 ﹤0.01% 866
2024
Q1 		$1K Buy
139
+24
+21% +$93 ﹤0.01% 824
2023
Q4 		$1K Buy
+115
New +$525 ﹤0.01% 655

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Avion Wealth's ADPT Position: Q2 2026 in Review

Avion Wealth held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 140 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

Avion Wealth first reported a position in ADPT in Q4 2023 and has held it in 10 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Avion Wealth held 140 shares of Adaptive Biotechnologies worth $3K as of Q2 2026.
  • Avion Wealth left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #902 holding.
  • Avion Wealth first reported a position in Adaptive Biotechnologies in Q4 2023 and has held it in 10 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.